Belgium's Agomab Therapeutics seeks up to $828.5 million valuation in US IPO - Reuters

Reuters | Jan. 29, 2026, 8:57 a.m. | Original
Belgium's Agomab Therapeutics seeks up to $828.5 million valuation in US IPO Reuters
US weekly jobless claims fall slightly; prior week's data revised up - Reuters US life expectancy jumps to a record 79 years in 2024 - Reuters